Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00444054 · ClinicalTrials.gov registry record · NA
The RECHARGE Low Carbohydrate Diet Trial for Metastatic Cancer
A NA study, sponsored by Albert Einstein College of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT00444054 is a NA study that has completed, run by Albert Einstein College of Medicine. The registered enrollment target is 10 participants.
The verdict
NCT00444054, a NA study, has completed, sponsored by Albert Einstein College of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
This study is for people whose cancer: * has resisted chemotherapy * are taking a break from chemotherapy * or are looking for an alternative to the toxic effects of chemotherapy The trial is looking to see if a very low carbohydrate diet can inhibit the growth of certain cancers. The two major goals of the RECHARGE study are to determine: * whether a very low carbohydrate diet can help participants reduce the amount of cancer in their bodies (as measured by a PET scan at the beginning and end of the study) * whether participants can feel well while maintaining their weight on a very low carbohydrate diet This research study is for people with advanced cancers who decline chemotherapy or want to take a break from chemotherapy and have cancers that primarily feed on blood sugar. Examples of such cancers include metastatic breast cancer, colon cancer, cervical and uterine cancers, ovarian cancers, and many others. The investigators' intervention consists of a 28-day diet of high protein foods such as fish, poultry, meats, eggs and cheese as well as plenty of vegetables. Participants may eat as much of the high protein foods as they wish and can eat up to two cups of vegetables per day. Participants strictly eliminate carbohydrate-containing foods. These foods include all starches and sweets (breads, pasta, rice, potatoes, cereals, fruit, cakes, candies, soda with sugar, etc.).
Interventions
- BEHAVIORAL Very low carbohydrate diet (approximately 20 grams per day)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2006-02 |
| Est. Completion | 2012-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00444054
The ClinicalTrials.gov registry entry for NCT00444054 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Albert Einstein College of Medicine, which has 175 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Very low carbohydrate diet (approximately 20 grams per day) is the first listed.
NCT00444054 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00444054 about?
NCT00444054 is a clinical study titled "The RECHARGE Low Carbohydrate Diet Trial for Metastatic Cancer". This study is for people whose cancer: * has resisted chemotherapy * are taking a break from chemotherapy * or are looking for an alternative to the toxic effects of chemotherapy The trial is looking to see if a very low carbohydrate diet can inhibit the growth of certain cancers. The two major g...
What is the current status of trial NCT00444054?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2006-02. Estimated completion is 2012-05.
What interventions are being tested in trial NCT00444054?
The interventions under investigation include: Very low carbohydrate diet (approximately 20 grams per day) (BEHAVIORAL).
Who is sponsoring clinical trial NCT00444054?
This trial is sponsored by Albert Einstein College of Medicine, which has 175 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.